Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma
Clinical trial NCT06070012 · RECRUITING
Trial details
- NCT number
- NCT06070012
- Sponsor
- Diwakar Davar
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-18
- Primary completion
- 2028-09-30
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.